Oct 9, 2025
Indocin (Indomethacin) vs. Common NSAID Alternatives - Detailed Comparison
The FDA's 2025 update to biosimilar approval rules removes outdated clinical trial requirements, speeding up access to lower-cost biologic alternatives for cancer, arthritis, and other chronic conditions.
